CEBPA mutation phasing using pacific biosciences circular consensus sequencing

Incidental cases of NIPT-associated maternal constitutional aberrations

Prenatal testing for hereditary cancer risk variants: Where are we now?

Genetic evaluation following MUTYH analysis for European founder variants is critical to identify at-risk patients: A laboratory's experience

The co-occurrence of MUTYH European founder variants and pathogenic variants in separate genes: One laboratory’s experiences and implications for genetic counseling on direct-to-consumer genetic test results